Atlas Trials

Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Clinical trial NCT03904927 · COMPLETED

Trial details

NCT number
NCT03904927
Sponsor
Fudan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
Start date
2019-02-01
Primary completion
2022-01-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.